YIPF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.32500010963099E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.01810054515306E-10 |
Normal-vs-Stage2 |
2.717000E-03 |
Normal-vs-Stage3 |
4.94330021361122E-10 |
Normal-vs-Stage4 |
1.51349999200079E-09 |
Stage1-vs-Stage2 |
5.389800E-01 |
Stage1-vs-Stage3 |
1.224170E-01 |
Stage1-vs-Stage4 |
3.550000E-01 |
Stage2-vs-Stage3 |
1.251980E-01 |
Stage2-vs-Stage4 |
2.761000E-01 |
Stage3-vs-Stage4 |
5.826000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.33200003751932E-09 |
Normal-vs-AfricanAmerican |
2.27495799975941E-12 |
Normal-vs-Asian |
1.525920E-02 |
Caucasian-vs-AfricanAmerican |
1.468210E-02 |
Caucasian-vs-Asian |
9.752800E-01 |
AfricanAmerican-vs-Asian |
3.289000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6213030917811E-11 |
Normal-vs-Female |
3.3403999999404E-07 |
Male-vs-Female |
1.528980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.0549000003316E-07 |
Normal-vs-Age(41-60Yrs) |
2.49049999512252E-08 |
Normal-vs-Age(61-80Yrs) |
3.52200490993937E-11 |
Normal-vs-Age(81-100Yrs) |
1.65961999999409E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.160050E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.127600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.380400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.481800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.327400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.669400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.499900E-02 |
Normal-vs-Grade 2 |
4.8437999999873E-07 |
Normal-vs-Grade 3 |
4.18731715967624E-12 |
Normal-vs-Grade 4 |
1.57600044126127E-10 |
Grade 1-vs-Grade 2 |
3.959000E-01 |
Grade 1-vs-Grade 3 |
3.400200E-02 |
Grade 1-vs-Grade 4 |
5.298400E-02 |
Grade 2-vs-Grade 3 |
2.024000E-02 |
Grade 2-vs-Grade 4 |
2.239900E-02 |
Grade 3-vs-Grade 4 |
5.004000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.50768999999107E-05 |
Normal-vs-ccB subtype |
2.58589816226618E-11 |
ccA subtype-vs-ccB subtype |
2.278200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.40020000833397E-09 |
Normal-vs-N1 |
1.173260E-04 |
N0-vs-N1 |
4.521200E-01 |
|
|